公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
2004 | Phase II study of combination doxorubicin, interferon-alpha, and high-dose tamoxifen treatment for advanced hepatocellular carcinoma. | Lu, YS; Hsu, C; Li, CC; Kuo, SH; Kun-Huei, Yeh; Yang, CH; Hsu, CH; Wu, CY; Cheng, AL. | Hepatogastroenterology | | | |
2005 | Phase II study of weekly paclitaxel and 24-hour infusion of high-dose 5-fluorouracil and leucovorin in the treatment of recurrent or metastatic gastric cancer. | Yeh, KH; Lu, YS; Hsu, CH; Lin, JF; Hsu, C; Kuo, SH; Li, SJ; Cheng, AL. | Oncology | | | |
2005 | Phase II study of weekly paclitaxel and 24-hour infusion of high-dose 5-fluorouracil and leucovorin in the treatment of recurrent or metastatic gastric cancer. | Yeh, KH; Lu, YS; Hsu, CH; Lin, JF; Hsu, C; Kuo, SH; Li, SJ; Cheng, AL. | Oncology | | | |
2005 | A Question of Trust-An Economics Analysis of Quality Standards in Certification Services Market | Backhouse, J; Hsu, C; Tseng, J; Baptista, J | Communications of the ACM | | | |
2008 | A revisit of prophylactic lamivudine for chemotherapy-associated hepatitis B reactivation in non-Hodgkin’s lymphoma: A randomized trial. | Hsu, C; Hsiung, CA; Su, IJ; Hwang, WS; Wang, MC; Lin, SF; Lin, TH; Hsiao, HH; Young, JH; Chang, MC; Liao, YM; Li, CC; Wu, HB; Tien, HF; Cho, TY; Liu, TW; Cheng, AL; Chen, PJ | Hepatology | | | |
2003 | Towards PKI Interoperability: Lessons from a BS7799 Accreditation Scheme | Backhouse, J.; Hsu, C; McDonell, A. | Communications of the ACM | | | |